Stay updated with breaking news from Biofarma Srl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global CMO/CDMO Market is anticipated to expand significantly, registering a CAGR of 5.7% from 2023 to 2033. In 2023, the global CMO/CDMO market is expected to be worth US$ 22.5 billion. By 2033, the market is expected to be worth US$ 39.4 billion.As more pharmaceutical companies consider outsourcing their opera...
As more pharmaceutical businesses contemplate outsourcing services, the need for services from contract manufacturing and contract development manufacturing organizations will grow. Future Industry Insights (FMI) believes that the CMO/CDMO Market has enormous potential for growth in the foreseeable future. The incre...
The global CMO/CDMO market is expected to post higher gains for 2020-2030. Increasing number of companies engaged in outsourcing services from contract manufacturing & contract development manufacturing organizations within pharmaceutical sector will boost the.As per FMI’s analysis, the rising demand for generic med...
(1) Increasing demand from the pharmaceutical industry and opportunities for new entrants are creating growth opportunities DUBAI, UAE / ACCESSWIRE / April 6, 2021 / The global CMO/CDMO market is expected to post higher gains for 2020-2030. Increasing number of companies engaged in outsourcing services from contract manufacturing & contract development manufacturing organizations within pharmaceutical sector will boost the. As per FMI's analysis, the rising demand for generic medicines and biologics & rising preference for local and natural products over big brands among consumers is paving t...